IPO

Recognises the use of IPRs as a strategic tool in commerce and industry

Will the bullish response to last year's IPOs in the pharma and healthcare sector spur more companies to test the market in 2016?…

The price band for the offer has been fixed between Rs 240 and Rs. 250 per equity share of Rs 10 each

Foreign investment limit raised to 44 per cent